Angina due to coronary artery spasm (variant angina): diagnosis and intervention strategies

References

• Prinzmetal M, Kennamer R, Merliss R, et al. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med. 1959;27(3):375–388.
   PubMed Web of Science ®Google Scholar
• Heberden W. Some account of a disorder of the breast. Medical Transactions Royal College of Physicians. Vol. 2. London. 1772
   Google Scholar
• Oliva PB, Potts DE, Pluss RG. Coronary arterial spasm in prinzmetal angina. documentation by coronary arteriography. N Engl J Med. 1973;288(15):745–751.
   PubMed Web of Science ®Google Scholar
• Curry RC. Prinzmetal’s angina. Provocative test and current therapy. JAMA. 1978;240(7):677–679.
   PubMed Web of Science ®Google Scholar
• Biagini A, Mazzei MG, Carpeggiani C, et al. Vasospastic ischemic mechanism of frequent asymptomatic transient ST-T changes during continuous electrocardiographic monitoring in selected unstable angina patients. Am Heart J. 1982;103(1):13–20.
   PubMed Web of Science ®Google Scholar
• Lanza GA, Maseri A. Coronary artery spasm. Curr Treat Options Cardiovasc Med. 2000;2(1):83–90.
   PubMedGoogle Scholar
• Maseri A, L’Abbate A, and Baroldi G, et al. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of “preinfarction” angina. N Engl J Med. 1978;299(23):1271–1277.
   PubMed Web of Science ®Google Scholar
• Maseri A, Pesola A, Marzilli M, et al. Coronary vasospasm in angina pectoris. Lancet. 1977;1(8014):713–717.
   PubMed Web of Science ®Google Scholar
• Maseri A, Severi S, Marzullo P. Role of coronary arterial spasm in sudden coronary ischemic death. Annals of the New York Academy of Sciences. 1982. 382(204–217)
   PubMedGoogle Scholar
• McFadden EP, Clarke JG, Davies GJ, et al. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med. 1991;324(10):648–654.
   PubMed Web of Science ®Google Scholar
• Pupita G, Maseri A, and Kaski JC, et al. Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris. N Engl J Med. 1990;323(8):514–520.
   PubMed Web of Science ®Google Scholar
• Lee DH, Park TK, Seong CS, et al. Gender differences in long-term clinical outcomes and prognostic factors in patients with vasospastic angina. Int J Cardiol. 2017;249(6–11):6–11.
   PubMedGoogle Scholar
• Maas A. Vasospastic angina behaves differently in men and women. Int J Cardiol. 2017;249(79–80):79–80.
   PubMedGoogle Scholar
• Wakabayashi K, Suzuki H, Shinmura K, et al. Cardiopulmonary arrest due to persistent coronary spasm in a young woman. Are we properly diagnosing vasospastic angina? Int J Cardiol. 2011;148(3):e56–59.
   PubMed Web of Science ®Google Scholar
• Kaski JC, Crea F, Meran D, et al. Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation. 1986;74(6):1255–1265.
   PubMed Web of Science ®Google Scholar
• Mortensen SA, Vilhelmsen R, Sandøe E. Non-pharmacological provocation of coronary vasospasm. Experience with prolonged hyperventilation in the coronary care unit. Eur Heart J. 1983;4(6):391–397.
   PubMed Web of Science ®Google Scholar
• Matta A, Bouisset F, Lhermusier T, et al. Coronary artery spasm: new insights. J Interv Cardiol. 2020;5894586-5894586:2020.
   Google Scholar
• Nobuyoshi M, Abe M, Nosaka H, et al. Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant. Am Heart J. 1992;124(1):32–38.
   PubMed Web of Science ®Google Scholar
• Mizuno Y, Harada E, Morita S, et al. East asian variant of aldehyde dehydrogenase 2 is associated with coronary spastic angina: possible roles of reactive aldehydes and implications of alcohol flushing syndrome. Circulation. 2015;131(19):1665–1673.
   PubMed Web of Science ®Google Scholar
• Yasue H, Mizuno Y, Harada E. Coronary artery spasm - Clinical features, pathogenesis and treatment. Proceedings of the Japan Academy. Series B, Physical and biological sciences, 95( 2),53–66 (2019).
   Google Scholar
• Kawana A, Takahashi J, Takagi Y, et al. Gender differences in the clinical characteristics and outcomes of patients with vasospastic angina–a report from the Japanese coronary spasm association. Circ J. 2013;77(5):1267–1274.
   PubMed Web of Science ®Google Scholar
• Sueda S, Suzuki J, Watanabe K, et al. Clinical characteristics of female patients with coronary spastic angina: comparison with male patients. Jpn Circ J. 2000;64(6):416–420.
   PubMedGoogle Scholar
• Waters DD, Miller DD, Szlachcic J, et al. Factors influencing the long-term prognosis of treated patients with variant angina. Circulation. 1983;68(2):258–265.
   PubMed Web of Science ®Google Scholar
• Halna du Fretay X, Ma B, Blanchard-Lemoine B, et al. [Is coronary artery spasm a disease specific to women?]. Ann Cardiol Angeiol. 2016;65(6):446–450.
   PubMedGoogle Scholar
• Kawano H, Motoyama T, Ohgushi M, et al. Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina. Ann Intern Med. 2001;135(11):977–981.
   PubMed Web of Science ®Google Scholar
• Wei J, Mehta PK, Johnson BD, et al. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women’s Ischemia Syndrome Evaluation) study. JACC Cardiovasc Interv. 2012;5(6):646–653.
   PubMed Web of Science ®Google Scholar
• AlBadri A, Mavromatis K, Bairey Merz CN. The role of coronary reactivity testing in women with no obstructive coronary artery disease. Curr Opin Cardiol. 2019;34(6):656–662.
   PubMed Web of Science ®Google Scholar
• Imam H, Nguyen TH, and Stafford I, et al. Impairment of platelet NO signalling in coronary artery spasm: role of hydrogen sulphide. Br J Pharmacol. 2021;178(7):1639–1650.
   PubMed Web of Science ®Google Scholar
• Reynolds HR, Srichai MB, Iqbal SN, et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation. 2011;124(13):1414–1425.
   PubMed Web of Science ®Google Scholar
• Pristipino C, Beltrame JF, Finocchiaro ML, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation. 2000;101(10):1102–1108.
   PubMed Web of Science ®Google Scholar
• Beltrame JF. Defining the coronary slow flow phenomenon. Circ J. 2012;76(4):818–820.
   PubMed Web of Science ®Google Scholar
• Beltrame JF, Limaye SB, Wuttke RD, et al. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J. 2003;146(1):84–90.
   PubMed Web of Science ®Google Scholar
• Beltrame JF, Limaye SB, and Horowitz JD. The coronary slow flow phenomenon–a new coronary microvascular disorder. Cardiology. 2002;97(4):197–202.
   PubMed Web of Science ®Google Scholar
• Mehta HH, Morris M, Fischman DL, et al. The spontaneous coronary slow-flow phenomenon: reversal by intracoronary nicardipine. J Invasive Cardiol. 2019;31(3):42–45.
   PubMed Web of Science ®Google Scholar
• Maseri A, Liuzzo G, Biasucci LM. Pathogenic mechanisms in unstable angina. Heart. 1999;82(Suppl 1 (Suppl1)):4–I2 .
   PubMedGoogle Scholar
• Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391(10115):31–40.
   PubMed Web of Science ®Google Scholar
• Kaski JC, Crea F, Gersh BJ, et al. Reappraisal of ischemic heart disease. Circulation. 2018;138(14):1463–1480.
   PubMed Web of Science ®Google Scholar
• Picard F, Sayah N, Spagnoli V, et al. Vasospastic angina: a literature review of current evidence. Arch Cardiovasc Dis. 2019;112(1):44–55.
   PubMed Web of Science ®Google Scholar
• Okonkwo K, Ojha U. Vasospasm induced myocardial ischaemia secondary to sumatriptan use. BMJ Case Rep. 2020;13(8):e235387.
   PubMedGoogle Scholar
• Miller D, Waters DD, and Warnica W, et al. Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med. 1981;304(13):763–766.
   PubMed Web of Science ®Google Scholar
• Kawakami T, Ohno H, Tanaka N, et al. The relationship between paroxysmal atrial fibrillation and coronary artery spasm. Pacing Clin Electrophysiol. 2014;37(5):591–596.
   PubMed Web of Science ®Google Scholar
• Abdelghany M, Subedi R, Shah S, et al. Kounis syndrome: a review article on epidemiology, diagnostic findings, management and complications of allergic acute coronary syndrome. Int J Cardiol. 2017;232:1–4.
   PubMed Web of Science ®Google Scholar
• Vishnevsky A, Julien HM, Fischman DL, et al. Unrecognized coronary vasospasm in patients referred for percutaneous coronary intervention: intracoronary nitroglycerin, the forgotten stepchild of cardiovascular guidelines. Catheter Cardiovasc Interv. 2017;90(7):1086–1090.
   PubMed Web of Science ®Google Scholar
• Pepine CJ. Provoked coronary spasm and acute coronary syndromes. J Am Coll Cardiol. 2008;52(7):528–530.
   PubMed Web of Science ®Google Scholar
• Elbadawi A, Elgendy IY, Naqvi SY, et al. Temporal trends and outcomes of hospitalizations with prinzmetal angina: perspectives from a national database. Am J Med. 2019;132(9):1053–1061.e1051.
   PubMed Web of Science ®Google Scholar
• Nguyen TH, Chirkov YY, Liu SF, et al. Increased rate of hospitalization with prinzmetal angina: what exactly is happening? Am J Med. 2020;133(4):e162–e163.
   PubMed Web of Science ®Google Scholar
• Shin ES, Ann SH, Singh GB, et al. OCT-Defined morphological characteristics of coronary artery spasm sites in vasospastic Angina. JACC Cardiovasc Imaging. 2015;8(9):1059–1067.
   PubMed Web of Science ®Google Scholar
• Beltrame JF, Crea F, Kaski JC, et al. International standardization of diagnostic criteria for vasospastic angina. Eur Heart J. 2017;38(33):2565–2568.
   PubMed Web of Science ®Google Scholar
• Ong P, Athanasiadis A, Borgulya G, et al. 3-year follow-up of patients with coronary artery spasm as cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study follow-up. J Am Coll Cardiol. 2011;57(2):147–152.
   PubMed Web of Science ®Google Scholar
• Sueda S, Kohno H, Ochi T, et al. Overview of the acetylcholine spasm provocation test. Clin Cardiol. 2015;38(7):430–438.
   PubMed Web of Science ®Google Scholar
• Vishnevsky A, Fischman DL, Savage MP. Intracoronary nitroglycerin: recognizing coronary spasm first and foremost to avoid unnecessary coronary stents. Expert Rev Cardiovasc Ther. 2017;15(10):727–728.
   PubMed Web of Science ®Google Scholar
• Waters DD, Szlachcic J, Bonan R, et al. Comparative sensitivity of exercise, cold pressor and ergonovine testing in provoking attacks of variant angina in patients with active disease. Circulation. 1983;67(2):310–315.
   PubMed Web of Science ®Google Scholar
• Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. Circ J: official journal of the Japanese Circulation Society. 2010. 748:1745–1762
   Google Scholar
• Yasue H, Horio Y, Nakamura N, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation. 1986;74(5):955–963.
   PubMed Web of Science ®Google Scholar
• Smith JB, Araki H, Lefer AM. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation. Circulation. 1980;62(6 Pt 2):V19–25.
   PubMed Web of Science ®Google Scholar
• Tohgi H, Konno S, Tamura K, et al. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke. 1992;23(10):1400–1403.
   PubMed Web of Science ®Google Scholar
• Miwa K, Kambara H, Kawai C. Effect of aspirin in large doses on attacks of variant angina. Am Heart J. 1983;105(2):351–355.
   PubMed Web of Science ®Google Scholar
• Park JY, Rha SW, Poddar KL, et al. Impact of low-dose aspirin on coronary artery spasm as assessed by intracoronary acetylcholine provocation test in Korean patients. J Cardiol. 2012;60(3):187–191.
   PubMed Web of Science ®Google Scholar
• Hangouche AJE, Lamliki O, Oukerraj L, et al. Kounis syndrome induced by oral intake of aspirin: case report and literature review. The Pan African medical journal. 2018;30(301).
   Google Scholar
• Lim AY, Park TK, and Cho SW, et al. Clinical implications of low-dose aspirin on vasospastic angina patients without significant coronary artery stenosis; a propensity score-matched analysis. Int J Cardiol. 2016;221161–166.
   Google Scholar
• Kern MJ, Ganz P, and Horowitz JD, et al. Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease. Circulation. 1983;67(6):1178–1185.
   PubMed Web of Science ®Google Scholar
• Turlapaty PDMV, Altura BM. Propranolol induces contractions of canine small and large coronary arteries. Basic Res Cardiol. 1982;77(1):68–81.
   PubMed Web of Science ®Google Scholar
• Kurabayashi M, Suzuki H, Shimura T, et al. Ventricular fibrillation in a patient with multi-vessel coronary spasm four days after the initiation of an oral beta-blocker. Eur J Case Rep Intern Med. 2016;3(5):000439.
   PubMedGoogle Scholar
• Tamura Y, Sakata K, Kawashiri M-A YM. Multi-vessel coronary vasospasm after beta-blocker administration. Intern Med. 2018;57(21):3219–3220.
   PubMed Web of Science ®Google Scholar
• Antman E, Muller J, Goldberg S, et al. Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. N Engl J Med. 1980;302(23):1269–1273.
   PubMed Web of Science ®Google Scholar
• Strauss WE. Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina. Rationale, efficacy, and adverse effects. Ann Intern Med. 1988;109(7):570–581.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Hata K, Takaoka H, et al. Sumatriptan provokes coronary artery spasm in patients with variant angina: possible involvement of serotonin 1B receptor. Int J Cardiol. 2007;114(2):188–194.
   PubMed Web of Science ®Google Scholar
• Waters DD, Théroux P, Szlachcic J, et al. Provocative testing with ergonovine to assess the efficacy of treatment with nifedipine, diltiazem and verapamil in variant angina. Am J Cardiol. 1981;48(1):123–130.
   PubMed Web of Science ®Google Scholar
• Ozdogru I, Zencir C, Dogan A, et al. Acute effects of intracoronary nitroglycerin and diltiazem in coronary slow flow phenomenon. J Invest Med: the official publication of the American Federation for Clinical Research. 2013;61(1): 45–49
   PubMed Web of Science ®Google Scholar
• Beltrame JF, Turner SP, Leslie SL, et al. The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon. J Am Coll Cardiol. 2004;44(1):57–62.
   PubMed Web of Science ®Google Scholar
• Kandabashi T, Shimokawa H, Miyata K, et al. Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm. Arteriosclerosis, thrombosis, and vascular biology. 2003;23(12): 2209–2214
   PubMed Web of Science ®Google Scholar
• Masumoto A, Mohri M, Shimokawa H, et al. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation. 2002;105(13):1545–1547.
   PubMed Web of Science ®Google Scholar
• Horowitz JD, Henry CA, Syrjanen ML, et al. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. Circulation. 1988;77(4):787–794.
   PubMed Web of Science ®Google Scholar
• Pasupathy S, Tavella R, and Grover S, et al. Early use of N-acetylcysteine with nitrate therapy in patients undergoing primary percutaneous coronary intervention for ST-Segment-elevation myocardial infarction reduces myocardial infarct size (the NACIAM Trial [N-acetylcysteine in acute myocardial infarction]). Circulation. 2017;136(10):894–903.
   PubMed Web of Science ®Google Scholar
• Takagi S, Goto Y, Hirose E, et al. Successful treatment of refractory vasospastic angina with corticosteroids: coronary arterial hyperactivity caused by local inflammation? Circ J. 2004;68(1):17–22.
   PubMed Web of Science ®Google Scholar
• Jeong MH, Park JC, Rhew JY, et al. Successful management of intractable coronary spasm with a coronary stent. Japanese Circ J. 2000;64(11): 897–900
   PubMedGoogle Scholar
• Ong P, Carro A, and Athanasiadis A, et al. Acetylcholine-induced coronary spasm in patients with unobstructed coronary arteries is associated with elevated concentrations of soluble CD40 ligand and high-sensitivity C-reactive protein. Coron Artery Dis. 2015;26(2):126–132.
   PubMed Web of Science ®Google Scholar
• Ogawa H, Hiramori K, Haze K, et al. Comparison of clinical features of non-Q wave and Q wave myocardial infarction. Am Heart J. 1986;111(3):513–518.
   PubMed Web of Science ®Google Scholar
• Robertson RM, Robertson D, Friesinger GC, et al. Platelet aggregates in peripheral and coronary-sinus blood in patients with spontaneous coronary-artery spasm. Lancet. 1980;2(8199):829–831.
   PubMed Web of Science ®Google Scholar
• Forman MB, Oates JA, and Robertson D, et al. Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med. 1985;313(18):1138–1141.
   PubMed Web of Science ®Google Scholar